SBIR/STTR Research Award

CURRENT BACTERIOCIDAL AND FUNGICIDAL AGENTS ARE UNSATISFACTORY FOR USE ON SENSITIVE SOFT TISSUE OR MUCOUS MEMBRANE.

Award identifier 8ec84faf246faa08595647e8ac61aef69e749638445d14f7009423d6aaf1e171Awarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1985

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
H. G. Pars Pharmaceutical Labo
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

CURRENT BACTERIOCIDAL AND FUNGICIDAL AGENTS ARE UNSATISFACTORY FOR USE ON SENSITIVE SOFT TISSUE OR MUCOUS MEMBRANE. THERE IS NO KNOWN CHEMICAL AGENT WHICH POSSESSES BROAD-RANGE BACTERIOCIDAL AND FUNGICIDAL ACTIVITY AND IS NONIRRITANT TOWARDS OCULAR TISSUE. THE DISCOVERY OF SUCH AN AGENT WOULD BE USEFUL FOR SUCH DIVERGENT PURPOSES AS STERILIZATION OF SOFT CONTACT LENSES, AS AN ANTIMICROBIAL AGENT FOR INFANT USE, OR FOR SURGICAL SCRUBS AND IN IN THIS PROJECT, WE WILL INITIATE A SYSTEMATIC SEARCH FOR SUCH AN AGENT BY THE UTILIZATION OF A CAREFULLY CHOSEN LEAD COMPOUND: CHLORHEXIDINE. THIS COMPOUND IS BACTERIOSTATIC WITH LITTLE FUNGISTATIC ACTIVITY. ALTHOUGH IT IS THE MOST SATISFACTORY COMPOUND CURRENTLY AVAILABLE FOR SOFT LENS USE, ITS DISADVANTAGES, PRIMARILY IRRITANCY, ARE WELL KNOWN IN THE EYE CARE INDUSTRY. WE WILL UTILIZE TWO APPROACHES SIMULTANEOUSLY TOWARD THE DISCOVERY OF A NEW AGENT. IN THE FIRST, THE LIPOPHILIC AND ELECTRONIC CHARACTER OF A SPECIFICALLY CHOSEN SET OF COMPOUNDS WILL BE CORRELATED, USING CRAIG-TOPLISS ANALYTIC TECHNIQUES, WITH BIOLOGICAL ACTIVITY. THE SECOND APPROACH WILL DEPEND UPON OUR NOVEL CONCEPTION OF THE ROLE OF ION CHELATION IN THE ACTIVITY OF THE LEAD COMPOUND. THE SITE OF CHELATION OF THIS MOLECULE WILL BE ALTERED TO EFFECT THE THERMODYNAMICS OF METAL ION CHELATION. IN ALL, FOURTEEN COMPOUNDS WILL BE SYNTHESIZED. THE COMPLETION OF THIS PROJECT WILL LEAD TOWARD THE DEVELOPMENT OF AGENTS OF IMPROVED BACTERIOCIDAL AND FUNGICIDAL ACTIVITY.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.